Innovative Eyewear (LUCYW) Competitors

Innovative Eyewear logo
$0.03 +0.00 (+9.57%)
As of 11/17/2026 03:11 PM Eastern
This is a fair market value price provided by Massive. Learn more.

LUCYW vs. NXGLW, WOK, MDLN, ALC, and WST

Should you buy Innovative Eyewear stock or one of its competitors? Innovative Eyewear's main competitors and comparable companies include NEXGEL (NXGLW), WORK Medical Technology Group (WOK), Medline (MDLN), Alcon (ALC), and West Pharmaceutical Services (WST). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Innovative Eyewear compare to NEXGEL?

Innovative Eyewear (NASDAQ:LUCYW) and NEXGEL (NASDAQ:NXGLW) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$3.41MN/AN/AN/AN/A
NEXGEL$12.07MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Innovative EyewearN/A N/A N/A
NEXGEL N/A N/A N/A

In the previous week, NEXGEL had 2 more articles in the media than Innovative Eyewear. MarketBeat recorded 2 mentions for NEXGEL and 0 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 1.43 beat NEXGEL's score of 0.71 indicating that Innovative Eyewear is being referred to more favorably in the media.

Company Overall Sentiment
Innovative Eyewear Positive
NEXGEL Positive

Summary

NEXGEL beats Innovative Eyewear on 2 of the 3 factors compared between the two stocks.

How does Innovative Eyewear compare to WORK Medical Technology Group?

Innovative Eyewear (NASDAQ:LUCYW) and WORK Medical Technology Group (NASDAQ:WOK) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Company Net Margins Return on Equity Return on Assets
Innovative EyewearN/A N/A N/A
WORK Medical Technology Group N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Eyewear
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
WORK Medical Technology Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, WORK Medical Technology Group's average media sentiment score of 1.79 beat Innovative Eyewear's score of 1.43 indicating that WORK Medical Technology Group is being referred to more favorably in the news media.

Company Overall Sentiment
Innovative Eyewear Positive
WORK Medical Technology Group Very Positive

Innovative Eyewear has higher earnings, but lower revenue than WORK Medical Technology Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$3.41MN/AN/AN/AN/A
WORK Medical Technology Group$9.81MN/A-$1.07MN/AN/A

Summary

WORK Medical Technology Group beats Innovative Eyewear on 3 of the 3 factors compared between the two stocks.

How does Innovative Eyewear compare to Medline?

Medline (NASDAQ:MDLN) and Innovative Eyewear (NASDAQ:LUCYW) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.

Medline has higher revenue and earnings than Innovative Eyewear.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medline$28.43B1.74$1.16B$0.4485.64
Innovative Eyewear$3.41MN/AN/AN/AN/A

In the previous week, Medline had 16 more articles in the media than Innovative Eyewear. MarketBeat recorded 16 mentions for Medline and 0 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 1.43 beat Medline's score of 0.89 indicating that Innovative Eyewear is being referred to more favorably in the news media.

Company Overall Sentiment
Medline Positive
Innovative Eyewear Positive

Medline currently has a consensus price target of $46.08, suggesting a potential upside of 22.28%. Given Medline's stronger consensus rating and higher possible upside, research analysts plainly believe Medline is more favorable than Innovative Eyewear.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medline
2 Sell rating(s)
4 Hold rating(s)
23 Buy rating(s)
0 Strong Buy rating(s)
2.72
Innovative Eyewear
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Medline has a net margin of 1.84% compared to Innovative Eyewear's net margin of 0.00%. Medline's return on equity of 8.21% beat Innovative Eyewear's return on equity.

Company Net Margins Return on Equity Return on Assets
Medline1.84% 8.21% 4.03%
Innovative Eyewear N/A N/A N/A

Summary

Medline beats Innovative Eyewear on 8 of the 9 factors compared between the two stocks.

How does Innovative Eyewear compare to Alcon?

Alcon (NYSE:ALC) and Innovative Eyewear (NASDAQ:LUCYW) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends.

Alcon has higher revenue and earnings than Innovative Eyewear.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alcon$10.40B3.53$980M$1.3754.16
Innovative Eyewear$3.41MN/AN/AN/AN/A

Alcon presently has a consensus price target of $82.16, indicating a potential upside of 10.72%. Given Alcon's stronger consensus rating and higher probable upside, equities research analysts plainly believe Alcon is more favorable than Innovative Eyewear.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alcon
1 Sell rating(s)
6 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.63
Innovative Eyewear
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Alcon has a net margin of 6.06% compared to Innovative Eyewear's net margin of 0.00%. Alcon's return on equity of 7.54% beat Innovative Eyewear's return on equity.

Company Net Margins Return on Equity Return on Assets
Alcon6.06% 7.54% 5.25%
Innovative Eyewear N/A N/A N/A

53.9% of Alcon shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Alcon had 17 more articles in the media than Innovative Eyewear. MarketBeat recorded 17 mentions for Alcon and 0 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 1.43 beat Alcon's score of 0.30 indicating that Innovative Eyewear is being referred to more favorably in the news media.

Company Overall Sentiment
Alcon Neutral
Innovative Eyewear Positive

Summary

Alcon beats Innovative Eyewear on 10 of the 11 factors compared between the two stocks.

How does Innovative Eyewear compare to West Pharmaceutical Services?

Innovative Eyewear (NASDAQ:LUCYW) and West Pharmaceutical Services (NYSE:WST) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

93.9% of West Pharmaceutical Services shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

West Pharmaceutical Services has higher revenue and earnings than Innovative Eyewear.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$3.41MN/AN/AN/AN/A
West Pharmaceutical Services$3.07B9.38$493.70M$8.9146.46

West Pharmaceutical Services has a net margin of 18.81% compared to Innovative Eyewear's net margin of 0.00%. West Pharmaceutical Services' return on equity of 21.78% beat Innovative Eyewear's return on equity.

Company Net Margins Return on Equity Return on Assets
Innovative EyewearN/A N/A N/A
West Pharmaceutical Services 18.81%21.78%15.99%

West Pharmaceutical Services has a consensus price target of $424.67, suggesting a potential upside of 2.58%. Given West Pharmaceutical Services' stronger consensus rating and higher possible upside, analysts plainly believe West Pharmaceutical Services is more favorable than Innovative Eyewear.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Eyewear
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
West Pharmaceutical Services
0 Sell rating(s)
1 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.93

In the previous week, West Pharmaceutical Services had 5 more articles in the media than Innovative Eyewear. MarketBeat recorded 5 mentions for West Pharmaceutical Services and 0 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 1.43 beat West Pharmaceutical Services' score of 1.04 indicating that Innovative Eyewear is being referred to more favorably in the media.

Company Overall Sentiment
Innovative Eyewear Positive
West Pharmaceutical Services Positive

Summary

West Pharmaceutical Services beats Innovative Eyewear on 10 of the 11 factors compared between the two stocks.

Get Innovative Eyewear News Delivered to You Automatically

Sign up to receive the latest news and ratings for LUCYW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LUCYW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LUCYW vs. The Competition

MetricInnovative EyewearHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$5.98B$7.82B$11.74B
Dividend YieldN/A1.68%2.47%4.47%
P/E RatioN/A36.1232.9827.06
Price / SalesN/A5.398.565.70
Price / CashN/A23.6221.0121.90
Price / BookN/A4.174.463.72
Net IncomeN/A$143.92M$3.52B$393.10M
7 Day PerformanceN/A-5.48%-5.93%-5.76%
1 Month PerformanceN/A-3.68%-4.57%-7.14%
1 Year PerformanceN/A-0.10%-1.93%-7.46%

Innovative Eyewear Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LUCYW
Innovative Eyewear
N/A$0.03
+9.6%
N/A-58.5%$0.00$3.41MN/A13
NXGLW
NEXGEL
N/A$0.01
-9.3%
N/A-96.8%$0.00$12.07MN/A19
WOK
WORK Medical Technology Group
N/A$1.16
-7.2%
N/A-100.0%$0.00$9.81MN/A238
MDLN
Medline
3.7947 of 5 stars
$40.91
+0.5%
$46.08
+12.6%
N/A$53.52B$30.68B92.9845,000
ALC
Alcon
3.4017 of 5 stars
$74.03
-1.5%
$82.89
+12.0%
-3.1%$37.17B$10.40B23.0525,942

Related Companies and Tools


This page (NASDAQ:LUCYW) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners